155 related articles for article (PubMed ID: 12654652)
1. In vivo antiretroviral activity of stampidine in chronically feline immunodeficiency virus-infected cats.
Uckun FM; Chen CL; Samuel P; Pendergrass S; Venkatachalam TK; Waurzyniak B; Qazi S
Antimicrob Agents Chemother; 2003 Apr; 47(4):1233-40. PubMed ID: 12654652
[TBL] [Abstract][Full Text] [Related]
2. In vivo pharmacokinetics and toxicity profile of the anti-HIV agent stampidine in dogs and feline immunodeficiency virus-infected cats.
Uckun FM; Waurzyniak B; Tibbles H; Venkatachalam TK; Erbeck D
Arzneimittelforschung; 2006 Feb; 56(2A):176-92. PubMed ID: 16570826
[TBL] [Abstract][Full Text] [Related]
3. Stampidine as a promising antiretroviral drug candidate for pre-exposure prophylaxis against sexually transmitted HIV/AIDS.
Uckun FM; Cahn P; Qazi S; D'Cruz O
Expert Opin Investig Drugs; 2012 Apr; 21(4):489-500. PubMed ID: 22360744
[TBL] [Abstract][Full Text] [Related]
4. In vivo toxicity, pharmacokinetics, and anti-human immunodeficiency virus activity of stavudine-5'-(p-bromophenyl methoxyalaninyl phosphate) (stampidine) in mice.
Uckun FM; Qazi S; Pendergrass S; Lisowski E; Waurzyniak B; Chen CL; Venkatachalam TK
Antimicrob Agents Chemother; 2002 Nov; 46(11):3428-36. PubMed ID: 12384347
[TBL] [Abstract][Full Text] [Related]
5. Antiretroviral spermicide WHI-07 prevents vaginal and rectal transmission of feline immunodeficiency virus in domestic cats.
D'Cruz OJ; Waurzyniak B; Uckun FM
Antimicrob Agents Chemother; 2004 Apr; 48(4):1082-8. PubMed ID: 15047505
[TBL] [Abstract][Full Text] [Related]
6. Stampidine as a novel nucleoside reverse transcriptase inhibit with potent anti-HIV activity.
Uckun FM
Arzneimittelforschung; 2006 Feb; 56(2A):121-35. PubMed ID: 16570821
[TBL] [Abstract][Full Text] [Related]
7. Toxicity and pharmacokinetics of stampidine in mice and rats.
Uckun FM; Chen CL; Lisowski E; Mitcheltree GC; Venkatachalam TK; Erbeck D; Chen H; Waurzyniak B
Arzneimittelforschung; 2003; 53(5):357-67. PubMed ID: 12854363
[TBL] [Abstract][Full Text] [Related]
8. Anti-retroviral activity of GMP-grade stampidine against genotypically and phenotypically nucleoside reverse transcriptase inhibitor resistant recombinant human immunodeficiency virus. An in vitro study.
Uckun FM; DuMez D; Qazi S; Tibbles H; Venkatachalam TK
Arzneimittelforschung; 2007; 57(2):112-21. PubMed ID: 17396622
[TBL] [Abstract][Full Text] [Related]
9. In vitro anti-HIV potency of stampidine alone and in combination with standard anti-HIV drugs.
Uckun FM; Qazi S; Venkatachalam TK
Arzneimittelforschung; 2005; 55(4):223-31. PubMed ID: 15901046
[TBL] [Abstract][Full Text] [Related]
10. Unmet challenges in HIV therapy and potential of stampidine.
Uckun FM
Arzneimittelforschung; 2006 Feb; 56(2A):117-20. PubMed ID: 16570820
[No Abstract] [Full Text] [Related]
11. Stampidine is a potent inhibitor of Zidovudine- and nucleoside analog reverse transcriptase inhibitor-resistant primary clinical human immunodeficiency virus type 1 isolates with thymidine analog mutations.
Uckun FM; Pendergrass S; Venkatachalam TK; Qazi S; Richman D
Antimicrob Agents Chemother; 2002 Nov; 46(11):3613-6. PubMed ID: 12384373
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of stavudine-5'-[p-bromophenyl methoxyalaninyl phosphate], stampidine, in mice, dogs, and cats.
Chen CL; Yu G; Venkatachalam TK; Uckun FM
Drug Metab Dispos; 2002 Dec; 30(12):1523-31. PubMed ID: 12433828
[TBL] [Abstract][Full Text] [Related]
13. Stampidine prevents mortality in an experimental mouse model of viral hemorrhagic fever caused by lassa virus.
Uckun FM; Petkevich AS; Vassilev AO; Tibbles HE; Titov L
BMC Infect Dis; 2004 Jan; 4():1. PubMed ID: 14720304
[TBL] [Abstract][Full Text] [Related]
14. Potency of stampidine against multi-nucleoside reverse transcriptase inhibitor resistant human immunodeficiency viruses.
Uckun FM; Venkatachalam TK; Qazi S
Arzneimittelforschung; 2006 Feb; 56(2A):193-203. PubMed ID: 16570827
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of stampidine against primary clinical human immunodeficiency virus isolates.
Uckun FM; Pendergrass S; Qazi S; Venkatachalam TK
Arzneimittelforschung; 2004; 54(1):69-77. PubMed ID: 14979612
[TBL] [Abstract][Full Text] [Related]
16. Development and evaluation of a thermoreversible ovule formulation of stampidine, a novel nonspermicidal broad-spectrum anti-human immunodeficiency virus microbicide.
D'Cruz OJ; Samuel P; Waurzyniak B; Uckun FM
Biol Reprod; 2003 Dec; 69(6):1843-51. PubMed ID: 12890726
[TBL] [Abstract][Full Text] [Related]
17. Antiviral therapy reduces viral burden but does not prevent thymic involution in young cats infected with feline immunodeficiency virus.
Hayes KA; Phipps AJ; Francke S; Mathes LE
Antimicrob Agents Chemother; 2000 Sep; 44(9):2399-405. PubMed ID: 10952586
[TBL] [Abstract][Full Text] [Related]
18. Is AZT/3TC therapy effective against FIV infection or immunopathogenesis?
Arai M; Earl DD; Yamamoto JK
Vet Immunol Immunopathol; 2002 Mar; 85(3-4):189-204. PubMed ID: 11943320
[TBL] [Abstract][Full Text] [Related]
19. Follow-Up of Viral Parameters in FeLV- or FIV-Naturally Infected Cats Treated Orally with Low Doses of Human Interferon Alpha.
Gomez-Lucia E; Collado VM; Miró G; Martín S; Benítez L; Doménech A
Viruses; 2019 Sep; 11(9):. PubMed ID: 31514435
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and adverse effects of the antiviral compound plerixafor in feline immunodeficiency virus-infected cats.
Hartmann K; Stengel C; Klein D; Egberink H; Balzarini J
J Vet Intern Med; 2012; 26(3):483-90. PubMed ID: 22551322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
